-- 
XTL Climbs Most in 2 Weeks on Plans To Buy MinoGuard Operations

-- B y   R o n i t   G o o d m a n
-- 
2011-03-24T15:22:06Z

-- http://www.bloomberg.com/news/2011-03-24/xtl-climbs-most-in-2-weeks-on-plans-to-buy-minoguard-operations.html
XTL Biopharmaceuticals Ltd. (XTLB)  rose
the most in more than two weeks after the biopharmaceutical
company signed a letter of principles to buy the operations of
MinoGuard Ltd.  The shares surged 8.6 percent, the biggest gain since March
9, to 0.504 shekel at the 4:30 p.m. close in  Tel Aviv , giving
the Nes Ziona, Israel-based company a market value of 102.8
million shekels ($29 million).  XTL said it will receive an exclusive license for all of
MinoGuardâ€™s technology in exchange for royalty and milestone
payments throughout the clinical-development process.  To contact the reporter on this story:
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  